Fjarde Ap Fonden Eli Lilly & CO Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Eli Lilly & CO stock. As of the latest transaction made, Fjarde Ap Fonden holds 175,414 shares of LLY stock, worth $137 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

175,414

Previous 172,514 1.68%

Holding current value

$137 Million

Previous $134 Million 15.79%

% of portfolio

1.59%

Previous 1.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $2.24 Million - $2.78 Million	2,900 Added 1.68%	175,414 $155 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $1.56 Million - $2.09 Million	2,633 Added 1.55%	172,514 $134 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $13.5 Million - $15.9 Million	-25,725 Reduced 13.15%	169,881 $99 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $3.43 Million - $4.73 Million	-7,900 Reduced 3.88%	195,606 $105 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $4 Million - $5.35 Million	11,400 Added 5.93%	203,506 $95.4 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.46 Million - $1.71 Million	-4,700 Reduced 2.39%	192,106 $66 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $5.97 Million - $6.95 Million	-18,562 Reduced 8.62%	196,806 $72 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $3.21 Million - $3.76 Million	11,500 Added 5.64%	215,368 $69.8 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $2.75 Million - $3.41 Million	-11,708 Reduced 5.43%	203,868 $58.4 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $2.95 Million - $3.67 Million	-13,140 Reduced 5.75%	215,576 $59.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.51 Million - $1.85 Million	-6,800 Reduced 2.89%	228,716 $52.8 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $4.6 Million - $5.96 Million	-25,500 Reduced 9.77%	235,516 $54.1 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $903,760 - $1.17 Million	5,500 Added 2.15%	261,016 $48.8 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $12.2 Million - $16.1 Million	93,400 Added 57.61%	255,516 $43.1 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $1.64 Million - $1.89 Million	11,200 Added 7.42%	162,116 $24 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $11.6 Million - $13.9 Million	-84,774 Reduced 35.97%	150,916 $24.8 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $1.35 Million - $1.67 Million	-11,300 Reduced 4.58%	235,690 $32.7 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $833,976 - $1.03 Million	7,800 Added 3.26%	246,990 $32.5 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $903,763 - $983,062	-8,463 Reduced 3.42%	239,190 $26.7 Million
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $1.93 Million - $2.25 Million	-17,400 Reduced 6.56%	247,653 $27.4 Million
Q1 2019 Apr 29, 2019	BUY	$111.31 - $131.02 $3.79 Million - $4.46 Million	34,055 Added 14.74%	265,053 $34.4 Million
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $3.16 Million - $3.54 Million	-29,800 Reduced 11.43%	230,998 $26.7 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $1.26 Million - $1.57 Million	-14,619 Reduced 5.31%	260,798 $28 Million
Q2 2018 Jul 12, 2018	SELL	$75.7 - $86.88 $123,618 - $141,875	-1,633 Reduced 0.59%	275,417 $23.5 Million
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $70,202 - $82,869	946 Added 0.34%	277,050 $21.4 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $3.32 Million - $3.56 Million	40,539 Added 17.21%	276,104 $23.3 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $314,137 - $348,661	4,076 Added 1.76%	235,565 $20.2 Million
Q2 2017 Aug 08, 2017	BUY	N/A	231,489	231,489 $19.1 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account